Integrated detection of multi- and extensively drug-resistant tuberculosis using the nitrate reductase assay

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 1, 2012, Pages 110-113

  Ramos, E ^a   Fissette, K ^a   De Rijk, P ^a   Palomino, J C ^a   Martin, Anandi ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

MDR TB; NRA; XDR TB

Indexed keywords

ISONIAZID; KANAMYCIN; NITRATE REDUCTASE; OFLOXACIN; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CONTROLLED STUDY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; GRYA GENE; GRYB GENE; HUMAN; INHA GENE; INTERMETHOD COMPARISON; KATG GENE; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NITRATE REDUCTASE ASSAY; PRIORITY JOURNAL; PROPORTION METHOD; RPOB GENE; RRS GENE; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; TURNAROUND TIME;

ANTITUBERCULAR AGENTS; COLORIMETRY; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMANS; ISONIAZID; KANAMYCIN; KANAMYCIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; NITRATE REDUCTASE; OFLOXACIN; PREDICTIVE VALUE OF TESTS; RIFAMPIN; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84555194745     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0129     Document Type: Article

References (19)

1. World Health Organization. Multidrug and extensively drugresistant TB (M/XDR-TB): global report on surveillance and response. WHO/HTM/TB/2010.320. Geneva, Switzerland: WHO, 2010.
2. Canetti G S, Froman J, Grosset P, et al. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ 1963; 29: 565-578.
3. World Health Organization. Use of liquid TB culture and drug susceptibility testing (DST) in low- and medium-income settings. Summary report of the Expert Group Meeting on the use of liquid culture media. Geneva, Switzerland: WHO, 2007. http://www.who.int/tb/laboratory/use-of-liquid-tb- culture- summary-report.pdf Accessed October 2011.
4. World Health Organization. Molecular line-probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB): policy statement. Geneva, Switzerland: WHO, 2008. http://www.who.int/tb/ laboratory/lpa-policy.pdf Accessed October 2011.
5. World Health Organization. Non-commercial culture and drug susceptibility testing methods for screening of patients at risk of multidrug-resistant tuberculosis: policy statement. Geneva, Switzerland: WHO, 2010. http://whqlibdoc.who.int/publications/ 2011/9789241501620-eng.pdf Accessed October 2011.
6. Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes; tentative standard. 2nd ed. Document M24-T2. Wayne, PA, USA: CLSI, 2000.
7. Angeby K A, Klintz L, Hoffner S E. Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay. J Clin Microbiol 2002; 40: 553-555.
8. Martin A, Palomino J C, Portaels F. Rapid detection of ofloxacin resistance in Mycobacterium tuberculosis by two low-cost colorimetric methods: resazurin and nitrate reductase assays. J Clin Microbiol 2005; 43: 1612-1616.
9. Kiepiela P, Bishop K S, Smith A N, Roux L, York D F. Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. Tubercle Lung Dis 2000; 80: 47-56.
10. Jugheli L, Bzekalava N, de Rijk P, Fissette K, Portaels F, Rigouts L. High level of cross-resistance between kanamycin, amikacin and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene. Antimicrob Agents Chemother 2009; 53: 5064-5068.
11. Von Groll A, Martin A, Jureen P, et al. Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB. Antimicrob Agents Chemother 2009; 53: 4498-4500.
12. Kapur V, Li L L, Iordanescu S, et al. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol 1994; 32: 1095-1098.
13. Brudey K, Driscoll J R, Rigouts L, et al. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 2006; 6: 23.
14. Martin A, Panaiotov S, Portaels F, Hoffner S, Palomino J C, Angeby K. The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 2008; 62: 56-64.
15. Rosales S, Pineda-García L, Andino N, Almendarez N, Membreño H, Hoffner S E. Evaluation of the nitrate reductase assay for rapid detection of extensively drug-resistant tuberculosis. Int J Tuberc Lung Dis 2009; 13: 1542-1549.
16. Visalakshi P, Meharwal S K, Myneedu V P, Behera D. Evaluation of direct method of drug susceptibility testing of Mycobacterium tuberculosis to rifampicin and isoniazid by nitrate reductase assay in a national reference laboratory. Diagn Microbiol Infect Dis 2010; 66: 148-152.
17. de Jong B C, Hill P C, Aiken A, et al. Clinical presentation and outcome of tuberculosis patients infected by M. africanum versus M. tuberculosis. Int J Tuberc Lung Dis 2007; 11: 450-456.
18. Martin A, Portaels F, Palomino J C. Colorimetric redox-indicator methods for the rapid detection of multidrug-resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 2007; 59: 175-183.
19. Minion J, Leung E, Menzies D, Pai M. Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2010; 10: 688-698.